Old Web
English
Sign In
Acemap
>
authorDetail
>
Clayton T. Hardman
Clayton T. Hardman
Stanford University
Bryostatin
Biology
Cancer immunotherapy
Bryostatin 1
T cell
3
Papers
113
Citations
0.00
KQI
Citation Trend
Filter By
Interval:
1900~2024
1900
2024
Author
Papers (3)
Sort By
Default
Most Recent
Most Early
Most Citation
No data
Journal
Conference
Others
Synthesis and evaluation of designed PKC modulators for enhanced cancer immunotherapy.
2020
Nature Communications
Clayton T. Hardman
Stephen Ho
Akira J. Shimizu
Quang Luu Nguyen
Jack L. Sloane
Mohamed S. A. Soliman
Matthew D. Marsden
Jerome A. Zack
Paul A. Wender
Show All
Source
Cite
Save
Citations (33)
Characterization of designed, synthetically accessible bryostatin analog HIV latency reversing agents.
2018
Virology
Matthew D. Marsden
Xiaomeng Wu
Sara M. Navab
Brian A. Loy
Adam J. Schrier
Brian A. DeChristopher
Akira J. Shimizu
Clayton T. Hardman
Stephen Ho
Christina M. Ramirez
Paul A. Wender
Jerome A. Zack
Show All
Source
Cite
Save
Citations (22)
Scalable synthesis of bryostatin 1 and analogs, adjuvant leads against latent HIV
2017
Science
Paul A. Wender
Clayton T. Hardman
Stephen Ho
Matthew S. Jeffreys
Jana K. Maclaren
Ryan V. Quiroz
Steven M. Ryckbosch
Akira J. Shimizu
Jack Sloane
Matthew C. Stevens
Show All
Source
Cite
Save
Citations (58)
1